Borealis was founded on the principle that great ideas and entrepreneurial talent existed in northern New England, but that access to early stage capital and experienced mentorship was lacking. We believe that this is still true. In 2012, Borealis began to deploy the Borealis Granite Fund, a pool of capital intended to nurture emerging technology companies in New Hampshire and to set the stage for their growth.

Portfolio Companies

logo-adimablogo-avedrologo-avitidelogo-builtrlogo-compasslogo-dynlogo-envistalogo-glycofilogo-handmarklogo-m2s2logo-newformalogo-scribe

Adimab Provides Year-End Update on 2017 Partnership Activities

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2017 it entered into agreements with seven new companies. In addition, Adimab announced the [...]

Lilly firms up Adimab R&D alliance, bringing its Ab platform in-house

Eli Lilly likes what it sees in Adimab's antibody R&D platform, opting to roll it out at sites in San Diego and New York to help its antibody discovery and optimization activities. The big pharma [...]

Avitide, Inc., Raises Series E Financing from Sands Capital Ventures

Avitide, Inc., the industry leader in the discovery, and manufacture of exclusive biopharmaceutical affinity purification solutions, today announced the closing of a Series E financing. Sands Capital Ventures, LLC led the financing round with participation [...]

Oracle Buys Dyn

Extends the World’s Most Comprehensive Cloud Computing Platform with the Leading Cloud-based Internet Performance and Domain Name System (DNS) Solution Oracle today announced that it has signed an agreement to acquire Dyn, the leading cloud-based [...]

Jesse Devitte

Contact Us

We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.

icon-phone 603.643.1500

icon-mail investors@borealisventures.com